EUVIMEDEUVIMED entdecken
Crossref

Drug response-based precision therapeutic selection for tamoxifen-resistant triple-positive breast cancer

Vinod S Bisht, Deepak Kumar, Mohd Altaf Najar, Kuldeep Giri, Jaismeen Kaur, Thottethodi Subrahmanya Keshava Prasad, Kiran Ambatipudi

Journal of Proteomics · 2025-01 · 310 · 105319

DOI: 10.1016/j.jprot.2024.105319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteomics, 2025-01. Verfasst von Vinod S Bisht und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India. Hauptthemen laut MEDLINE: Tamoxifen, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Indian Institute of Technology Roorkee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TamoxifenDrug Resistance, NeoplasmHumansFemaleMCF-7 CellsBreast NeoplasmsDoxorubicinPrecision MedicineAntineoplastic AgentsCisplatin

Stichwörter der Autor:innen

Drug cytotoxicityPrecision medicineProteomicsSpheroidTamoxifen-resistant

Substanzen

TamoxifenDoxorubicinAntineoplastic AgentsCisplatin

Autor:innen und Institutionen

  • Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India.
  • Department of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific & Innovative Research, Ghaziabad, Uttar Pradesh 201002, India.
  • Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India.
  • Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, India. Electronic address: kiran.ambatipudi@bt.iitr.ac.in.

Förderung

  • Indian Institute of Technology Roorkee

Zitieren

APA

Bisht, V. S., Kumar, D., Najar, M. A., Giri, K., Kaur, J., Prasad, T. S. K., & Ambatipudi, K. (2025). Drug response-based precision therapeutic selection for tamoxifen-resistant triple-positive breast cancer. Journal of Proteomics, 310, 105319. https://doi.org/10.1016/j.jprot.2024.105319

Vancouver

Bisht VS, Kumar D, Najar MA, Giri K, Kaur J, Prasad TSK, et al. Drug response-based precision therapeutic selection for tamoxifen-resistant triple-positive breast cancer. Journal of Proteomics. 2025;310:105319. doi:10.1016/j.jprot.2024.105319

BibTeX
@article{Bisht2025,
  author = {Bisht, Vinod S and Kumar, Deepak and Najar, Mohd Altaf and Giri, Kuldeep and Kaur, Jaismeen and Prasad, Thottethodi Subrahmanya Keshava and Ambatipudi, Kiran},
  title = {Drug response-based precision therapeutic selection for tamoxifen-resistant triple-positive breast cancer},
  journal = {Journal of Proteomics},
  year = {2025},
  volume = {310},
  pages = {105319},
  doi = {10.1016/j.jprot.2024.105319}
}
Kostenlos starten →